For over a decade, CMS has been running a quiet experiment: can you redesign payment models fast enough to keep pace with what health systems are learning about managing risk? MSSP was the first serious attempt. ACO REACH refined it. The CMS LEAD model, launching January 1, 2027, is something different. It's the first ACO model designed not for a single performance cycle, but for the long arc of what sustained accountable care actually requires.
That distinction matters more than it might appear. The structural problems that caused high-performing ACOs to question whether MSSP or REACH economics justified the commitment weren't policy failures. They were design choices that made short-term sense and created long-term friction. LEAD is CMS' attempt to correct those choices at the architecture level.
Understanding what changed, and why, is the strategic work worth doing now.
The Problem LEAD Is Actually Solving
The central frustration of MSSP's benchmark design has been well-documented among ACO leaders, even if it hasn't always been named directly. Organizations that managed their populations well, reduced utilization, and closed care gaps consistently were rewarded in year one and penalized in year two. The mechanism: rebasing. As observed spending fell, the benchmark reset to reflect it. The next year's savings target started from a lower floor. Strong performers found themselves on a treadmill where the incentive to improve was continuously consumed by the improvement itself.
REACH addressed some of MSSP's limitations but retained rebasing. It also left unresolved a structural problem that has constrained ACO performance since the beginning: specialist accountability. ACOs have always been responsible for total cost of care, but the specialists and post-acute providers driving a large share of that cost operated entirely outside the ACO's financial relationship. Primary care managed the patient. Specialists managed the episode. The ACO absorbed the consequence.
LEAD is a direct response to both of these problems.
What the CMS LEAD Model Actually Is
LEAD, the Long-term Enhanced ACO Design model, is a 10-year performance model and the longest-running ACO program in CMMI history. The duration is not a cosmetic feature. It is the mechanism through which most of LEAD's structural improvements produce value. A fixed benchmark compounds differently over 10 years than it does over three. A preferred provider relationship built over five years is a different kind of infrastructure than one negotiated under a two-year contract horizon.
The core mechanics:
No benchmark rebasing. LEAD sets a historical spending baseline from calendar years 2024 through 2026. That baseline is locked for the entire 10-year model, trended forward each year using national and regional growth rates plus the Accountable Care Prospective Trend (ACPT). The underlying expenditure history is never recalculated from observed performance. This is the structural opposite of MSSP's rebasing cycle, and the third article in this series covers the financial implications in detail.
First-dollar savings. LEAD eliminates the Minimum Savings Rate threshold. Savings begin the moment actual costs fall below the benchmark. For organizations that consistently generated savings just below the MSSP MSR cutoff and received nothing for it, this is a direct correction built into the model's foundation.
Two risk tracks. Global Risk ACOs take on 100% of savings and losses. Professional Risk ACOs take on 50%. Global participants carry a small benchmark discount of approximately 1.75 to 3% in exchange for full participation.
Primary Care Capitation. Global Risk ACOs can elect monthly per-beneficiary payments upfront, approximately 7% of the benchmark. This option exists for organizations managing complex populations where administrative overhead and care management investment precede settlement revenue by months.
High Needs beneficiary category. LEAD creates a distinct subpopulation for dually eligible, homebound, and home-limited patients with complex chronic conditions. This group receives concurrent risk adjustment: risk scores update during the performance year to reflect actual health status, not just prior-year diagnosis data. For organizations that have long argued that prospective-only risk adjustment understates what it costs to care for their most complex patients, this is the structural acknowledgment they were right.
What This Means for How ACOs Should Think About LEAD
The instinct to evaluate LEAD against MSSP is understandable but limiting. The better frame is to ask what kind of organization LEAD was designed to reward over a decade, and whether that description matches yours.
LEAD's design consistently favors organizations with three characteristics: the infrastructure to manage complex populations accurately, the actuarial sophistication to model a benchmark they can't fully observe, and the relationships to bring specialists into genuine cost accountability. None of these are new capabilities. Most serious ACOs have some version of all three. What LEAD does is make those capabilities financially consequential for 10 consecutive years rather than rewarding them in year one and recalibrating the target in year two.
The formal specialist integration mechanism, CARA (CMS-Administered Risk Arrangements), deserves particular attention. It's covered in the final article in this series, but its presence in LEAD is itself a policy signal: CMS has concluded that primary-care-centric accountability has reached its ceiling. The next phase of ACO performance improvement runs through specialists. The organizations positioning their preferred provider relationships now, before CARA episodes activate in 2028, will enter that phase with infrastructure already in place.
Who Can Participate
LEAD is deliberately designed to attract a broader participant base than REACH.
Existing REACH participants have a simplified on-ramp and can carry forward the population management infrastructure they've built. MSSP organizations can apply. Rural, small, and independent practices new to ACOs are eligible. Organizations serving high-needs and dually eligible populations are an explicit policy target, which explains the High Needs concurrent risk adjustment and the benefit enhancements covered in the second article in this series.
The application window for the first cohort closed May 17, 2026. The implementation period (no financial risk) runs September through December 2026. Performance Year 1 begins January 1, 2027. The model runs through December 31, 2036. Future cohorts are expected.
The Honest Position
Ten years is a long time. CMS has never run an accountable care model at this scale or duration, and the ACPT assumption that drives annual benchmark trending is a genuine uncertainty, particularly for organizations in markets where historical cost trends have diverged from national averages. The mid-model transition to rate-book-based benchmarks, expected roughly midway through the performance period, adds a variable that actuarial teams should be modeling now rather than when it arrives.
LEAD is not a risk-free model. The Global track carries real two-sided exposure. The structural improvements over MSSP and REACH are meaningful, but they don't change the fundamental nature of the commitment: a decade of performance risk against a benchmark you can only partially observe, in a policy environment that could shift.
What LEAD does offer is a model where strong performance produces compounding returns rather than tightening constraints. That's a different proposition than what came before. Whether it's the right proposition for a given organization depends on the sophistication of its population health infrastructure, the quality of its actuarial modeling, and the maturity of its specialist relationships.
The REACH-to-LEAD transition is a data strategy and workflow decision as much as a policy one. Ensuring benchmark data, HCC capture workflows, and population attribution logic are aligned to LEAD's specific methodology before January 1 is operational work that needs to start well before the model launches. Innovaccer's Population Health Operating System™ supports MSSP, ACO REACH, LEAD, and ACCESS simultaneously on one platform, so organizations in transition don't rebuild programs from scratch each time CMS moves the goalposts. For organizations managing complex chronic conditions under LEAD, Story Health by Innovaccer provides specialist-integrated managed care programs for heart failure and CKD that operate within the ACO's financial and data structure.
Whether you've already applied for LEAD or are still weighing it, our VBC experts can help you define a Medicare strategy for 2027 and beyond that works across MSSP, LEAD, ACCESS etc.
Connect with our VBC experts.
